IL10 and inflammatory bowel disease: Within the Nutrigenomics New Zealand programme, two mouse models of IBD were primarily utilized: the interleukin-10 gene-deficient (Il10−/−) mouse [79,80,81], and the multiple drug resistance (Mdr1a) mouse [82,83,84].